Non-pharmacological treatment in kidney disease caused by diabetes
DOI:
https://doi.org/10.47196/diab.v51i3.106Keywords:
chronic kidney disease, minerals, proteins, tobaccoAbstract
The non-pharmacological treatment of chronic kidney disease (CKD) consists in regulating sodium consumption, abandoning cigarette smoking, perform physical activity and attain weight loss in case of overweight/obesity. The diagnosis and adequate treatment of malnutrition and intake control potassium, phosphorus and calcium should be considered. A meal plan with controlled proteins between 0.8 to 0.9 g/kg weight is recommended to people with diabetic kidney disease until stage 5. The evaluation and monitoring of dietary consumption and macro and micronutrients recommended in patients with CKD especially in advance stages, where the malnutrition risk is greater.
References
KDIGO 2012. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supl 2013;3:1.
Jones-Burton C, Mishra SI, Fink JC, et al. An in depth review of evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol 2006; 26(3):268-75.
Orth SR, Hallan SI. Smoking: a risk factor for progres- sion of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients absence of evidence or evidence of absence? Clin J Am Soc Nephrol 2008; 3(1):226-36.
Hallan SI, Orth SR. Smoking is a risk factor in the pro- gression to kidney failure. Kidney Int 2011; 80(5):516- 523.
Sawicki PT, Didjurgeit U, Muhlhauser I, et al. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994; 17(2):126-31.
Beddhu S, Baird B, Zitterkoph, et al. Physical activity and mortality in chronic kidney disease (NHANES III) Clin J Am Soc Nephrol 2009; 4:1901-1906.
Padilla J, Krasnoff J, Da Silva M, et al. Physical functio- ning in patients with chronic kidney disease. J Nephrol 2008; 21:550-559.
Johansen K, Chertow G, Ng A, et al. Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int 2000; 57(6):2564-70.
Hall JE, Crook ED, Jones DW, et al. Mechanisms of obe- sity associated cardiovascular and renal disease. Am J Med Sci 2002; 324(3):127-37.
Wahba IM, Mak RH. Obesity and obesity initiated metabolic síndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2007; 2(3):550-62.
Hobbs H, Farmer C, Irving J, et al. Is high body mass index independently associated with diminished glomerlar filtration rate? An epidemiological study. J Renal Care 2011; 37(3):148-154.
Wang Y, Chen X, Song Y, et al. Association between obe- sity and kidney disease: a sistematic review and meta analysis. Kidney Int 2008; 73(1):19-33.
Navaneethan SD, Yehnert H, Moustarah F, et al. Weight loss interventions in chronic kidney disease: a sistema- tic review and meta-analysis. Clin J Am Soc Nephrol 2009; 4(9):1565-74.
Afshinnia F, Wilt RJ, Duval S, et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol DialTransplant 2010; 25(4):1173-83.
Gallieni M, Cupisti A. DASH and Mediterranean Diets as nutritional interventions for CKD patients. Am J Kidney Dis 2016; 68(6):828-830.
Imam TH, Fischer H, Jing B, et al. Estimated GFR befo- re and after bariatric surgery in CKD. Am J Kidney Dis 2017; 69(3):380-388.
Ollero D, Riobo P, Sánchez Vilar O, et al. Soporte nutricional en la insuficiencia renal crónica. Endocrinol Nutr 2005; 52(supl 2): 5-58.
KDOQI 2007. Clinical practice guidelines and clinical practice recommendations for diabetes and CKD disease. Guideline 5: nutritional management in diabetes and chronic kidney disease. Am J Kidney Dis 2007; 49:2 (suppl 2) S95-S107.
Riella M, Martins C. Nutrición en la progresión de la insuficiencia renal crónica. En: Nutrición y riñón, 2º Ed. Editorial Panamericana 2006; cap. 10, 97-109.
Academy of Nutrition and Dietetics Evidence Analysis Library. Chronic kidney disease evidence based nutrition practice guidelines. 2010. Disponible en: http://www.andel.org.
Pan Y, Guo LL, Jin HM. Low protein diet for diabetic ne- phropathy: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008; 88(3):660-6.
Robertson L, WaughN, Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev 2007; 17(4)CD002181.
Academy of Nutrition and Dietetics Evidence Analysis Library. Diabetes type 1 and 2 evidence based Nutrition practice guidelines for adults. 2015. Disponible en: http://www.andel.org.
Azadbakht L, Atabak S, Esmailizadeh A. Soy protein, cardiorenal índices and creactive protein in type 2 diabetes with nephroparhy. Diabetes Care 2008; 31:648-654.
Piccoli GB, Ventrella F, Capizzi I, et al. Low protein diets in diabetic chronic kidney disease (CDK) patients: are they feasible and worth the effort? Nutrients 2016; 8(10):649
Piccoli GB, Vigotti FN, Leone F, et al. Low protein diets in CKD: how can achieve them? A narrative, pragmatic review. Clin Kidney J 2015; 8(1):61-70.
Kiuchi A, Ohashi Y, Tai R, et al. Association betwen low dietary protein intake and geriatric nutrition risk index in patients with chronic kidney disease. A retrospective single center cohort study. Nutrients 2016; 8(10):662.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
